US EditionSenate panel questions Trump nominee to lead National Institutes of Health
- Dr. Jay Bhattacharya, President Donald Trump's nominee to lead the National Institutes of Health, assured senators he would restore trust in public health and focus on chronic diseases during his confirmation hearing on March 5, 2025.
- During the confirmation hearing, Bhattacharya confirmed there is no link between vaccines and autism but acknowledged that public distrust may necessitate more research to clarify the issue.
- Senator Susan Collins expressed strong opposition to a 15 percent cap on indirect costs for NIH grants, stressing that it is illegal and could negatively impact biomedical research in her state.
- Bhattacharya emphasized the importance of funding research that has meaningful outcomes, particularly concerning health disparities among minority populations.
24 Articles
24 Articles
Trump NIH appointee defends president's research funding cuts, lays out new vision for future
Donald Trump's pick to lead the NIH was peppered with questions from Democrats about the president's cuts to NIH research funding during his confirmation hearing Wednesday.
Trump NIH nominee aims to soothe senators over embattled agency
President Donald Trump’s nominee to lead the National Institutes of Health sought to reassure senators Wednesday that he would bring stability to an agency that has faced mass terminations and frozen funding of health research since Trump took office. Jay Bhattacharya, a Stanford health economist who faced criticism for his suggested approach to the COVID-19 pandemic, told senators he aims to restore trust in public health and science, bring mo…
LIVE NOW: Nomination of Jayanta Bhattacharya as NIH Director: Senate Health Committee Hearing
U.S. Senate Health, Education, Labor, and Pensions Committee holds a hearings to examine the nomination of Jayanta Bhattacharya, of California, to be Director of the National Institutes of Health, Department of Health and Human Services at 10 a.m. ET on Mar. 5. ...
Coverage Details
Bias Distribution
- 38% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
